Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHADD over fentanyl patch for breakthrough pain
NCT00278824Phase 2Terminated
- Sponsor
- ZARS Pharmaceuticals
- Start
- Jan 2006
- Primary completion
- Aug 2006
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in breakthrough pain and chronic pain comparing Fentanyl Patch + CHADD with Placebo Patch (2 arms). Primary endpoints: Numeric Rating Scale for Pain Intensity, Verbal Rating Scale for Pain Relief and 1 more. Started Jan 2006; status: terminated.
02
Drugs
fentanyl (transdermal patch + oral transmucosal lozenge)
03
Conditions
breakthrough painchronic pain
Beyond the preview
Go deeper on NCT00278824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00278824.